Quantum BioPharma Ltd
Company Profile
Business description
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
Contact
199 Bay Street
Suite 4000
TorontoONM5L 1A9
CANT: +1 416 854-8884
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
8
Stocks News & Analysis
stocks
10 of the cheapest global companies with wide moats
stocks
Bookworm: Buy and hold inspiration from an unlikely source
stocks
3 ASX shares to avoid
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,082.10 | 68.80 | 0.86% |
CAC 40 | 8,062.41 | 34.13 | 0.43% |
DAX 40 | 23,043.00 | 56.18 | 0.24% |
Dow JONES (US) | 41,488.19 | 674.62 | 1.65% |
FTSE 100 | 8,654.98 | 22.65 | 0.26% |
HKSE | 24,145.57 | 185.59 | 0.77% |
NASDAQ | 17,754.09 | 451.07 | 2.61% |
Nikkei 225 | 37,396.52 | 343.42 | 0.93% |
NZX 50 Index | 12,166.14 | 100.11 | -0.82% |
S&P 500 | 5,638.94 | 0.00 | 0.00% |
S&P/ASX 200 | 7,854.10 | 64.40 | 0.83% |
SSE Composite Index | 3,426.13 | 6.57 | 0.19% |